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The glycoprotein 130 (gp130) family consti-
tutes the signaling receptors for the IL-6/IL-12 
family of cytokines that includes IL-6, -11, -12, 
-23, and -27, cardiotrophin-1, cardiotrophin-
like cytokine, leukemia inhibitory factor, and 
oncostatin M (1), many of which have impor-
tant pro- and antiinfl  ammatory functions as 
well as roles in regulating the development and 
diff  erentiation of immune cells (2, 3). The most 
recent addition to this family was the gp130-
like monocyte receptor or IL-31Rα, which 
heterodimerizes with oncostatin M receptor β 
to form the IL-31R signaling complex and is 
expressed in the testis, thymus, bone marrow, 
and skin (4–7). Signaling via IL-31R results in 
the phosphorylation of STAT1, STAT5, and, 
most prominently, STAT3 (4–7). The ligand 
for IL-31R, IL-31, is expressed by activated 
CD4+ T cells, predominantly of the Th2 sub-
set. Recent studies in both humans and mice 
have suggested a link between IL-31–IL-31R 
expression and skin infl  ammation (7–11) although 
the functional signifi  cance of endo  genous IL-31–
IL-31R interactions in infl  uencing innate and 
adaptive immune responses remains unknown. 
In this paper, we describe the generation of 
IL-31Rα−/− mice and demonstrate a role for 
IL-31R signaling in limiting the magnitude of 
type 2 infl  ammation in the lung.
RESULTS AND D  I  S  C  U  S  S  I  O  N 
Normal development and composition 
of the immune system in IL-31R𝗂−/− mice
To determine the functions of endogenous IL-
31–IL-31R interactions, IL-31Rα−/− mice 
were generated by homologous recombination. 
The four exons encoding the ligand-binding 
cytokine receptor homology domain (exons 5–8) 
were replaced by a neomycin resistance c  assette 
(Fig. 1 A). Correct homologous recombination 
was confi  rmed by Southern blot analysis (Fig. 
1, B and C) and the absence of IL-31Rα ex-
pression confi  rmed by Taqman PCR (Fig. 1 D). 
Comprehensive fl   ow cytometric analysis of 
thymocytes, splenocytes, lymph node cells, and 
peripheral blood leukocytes did not indicate 
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any substantial diff  erences between naive WT and IL-31Rα−/− 
animals in the composition of immune cells in these compart-
ments (Table S1, available at http://www.jem.org/cgi/content/
full/jem.20061791/DC1). Importantly, analysis of peripheral 
blood did not reveal substantial anemia or thrombocytopenia, 
which has been reported for mice defi  cient in oncostatin M 
receptor β (12).
Mice defi  cient in IL-31R𝗂 develop exacerbated type 2 
infl  ammation in the lung after Schistosoma mansoni 
egg injection
Given the predominant expression of IL-31 in Th2 cells (7), 
we investigated the potential regulatory functions of IL-31–
IL-31R interactions in an in vivo model of type 2 infl  amma-
tion. Upon intravenous injection, S. mansoni eggs travel 
through the bloodstream and become lodged in the small 
blood vessels of the lung where they induce the formation of 
IL-4– and IL-13–dependent type 2 granulomas (13). After 
delivery of S. mansoni eggs, WT mice developed characteris-
tic egg-induced granulomas composed of a cuff   of epithelioid 
macrophages surrounded by granulocytes and lymphocytes 
(Fig. 2 A). In contrast, egg-injected IL-31Rα−/− mice devel-
oped more severe infl  ammation in the lung parenchyma as-
sociated with a greater than twofold increase in the mean area 
of infl  ammation surrounding each egg as well as increased 
granulocyte infi  ltration (Fig. 2, A and B). Draining mediasti-
nal lymph node cells were isolated from egg-injected WT 
and IL-31Rα−/− mice and restimulated with S. mansoni egg 
antigen. The S. mansoni egg-induced granuloma model can 
either use preimmunization with S. mansoni eggs systemically 
followed by i.v. challenge or direct i.v. primary challenge 
without prior sensitization. Direct primary challenge i.v. re-
sults in relatively low expression of Th2 cytokines but in the 
development of granulomas in the lung parenchyma (14). 
Consistent with this, after primary challenge with S. mansoni 
eggs, lymph node cells isolated from injected WT mice pro-
duced detectable levels of IL-5 but no IL-4 or IL-13. In con-
trast, lymph node cells from IL-31Rα−/− mice exhibited 
signifi  cantly higher levels of IL-4, IL-5, and IL-13 after antigen-
specifi  c restimulation (P < 0.05; Fig. 2 C). No cytokines 
were detected in antigen-stimulated lymph node cells from 
naive WT or IL-31Rα−/− mice (unpublished data). S. mansoni 
egg-injected IL-31Rα−/− mice also exhibited signifi-
cantly increased serum IgE levels compared with WT mice 
(Fig. 2 D), which is consistent with increased expression of 
Th2 cytokines.
Alternatively activated macrophages (AAMs) are a domi-
nant feature of S. mansoni egg-induced granulomas (15). Dif-
ferentiation of AAMs is dependent on Th2 cytokines, and 
this macrophage population expresses arginase and resistin-
like molecule α (RELM-α) and has been implicated in gran-
uloma formation, tissue remodeling, and fi  brosis  (16–18). 
Consistent with exacerbated expression of Th2 cytokines and 
increases in AAMs, the frequency of RELM-α+ cells was in-
creased in the lung granulomas of egg-injected IL-31Rα−/− 
mice (Fig. 2 E). RELM-α and arginase expression have been 
correlated with increases in collagen deposition and fi  brosis 
(19–21), and, accordingly, elevated collagen deposition was 
observed in the lungs of injected IL-31Rα−/− mice com-
pared with WT counterparts (Fig. 2 F). In total, the increased 
Figure 1.  Generation of IL-31R𝗂−/− mice. (A) The relevant section of 
the native IL-31Rα locus (top), the targeting construct (middle), and the 
correctly targeted locus (bottom) are depicted. Open boxes with numbers 
indicate exons and gray boxes indicate the selection genes neomycin 
phosphotransferase (NEO) and thymidine kinase (TK), with white arrow-
heads depicting their transcriptional orientation. Thick black lines indicate 
the position of the 5′ and 3′ homology arms. The size of restriction fragments 
resulting from digestion with SacI (S) and BamHI (B) are indicated, and 
the location of the two probes used to detect these fragments by Southern 
blot are shown by thick gray lines. (B and C) Southern blot analysis of SacI 
digests probed with probe 1 and BamHI digests probed with probe II, respec-
tively. Genotype is indicated as follows: +/+, WT; +/−, heterozygous; 
−/−, IL-31Rα−/−. (D) Expression of IL-31Rα relative to rpl19 was deter-
mined by quantitative Taqman PCR.JEM VOL. 204, March 19, 2007  483
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granuloma sizes, exacerbated Th2 cytokine production, high 
serum IgE levels, elevated frequency of RELM-α+ cells, and 
enhanced collagen deposition in the lung parenchyma are 
  indicative of dysregulated acute type 2 infl  ammation in the 
absence of IL-31R signaling.
IL-31R signaling infl  uences the proliferation 
and cytokine production of naive CD4+ T cells after 
polyclonal stimulation
S. mansoni egg-induced granuloma formation is dependent 
on CD4+ Th2 cytokine responses, and a previous study has 
reported that IL-31 and IL-31R are up-regulated by acti-
vated human T cells (7). To test if IL-31R signaling directly 
infl  uenced CD4+ T cell function and could contribute to the 
dysregulated type 2 infl  ammation in the lungs of IL-31Rα−/− 
mice, purifi  ed naive CD44lowCD62Lhigh CD4+ T cells from 
WT or IL-31Rα−/− mice were CFSE labeled and stimulated 
under neutral conditions with plate-bound anti-CD3/anti-
CD28. 4 d after stimulation, IL-31Rα−/− CD4+ T cells 
  exhibited enhanced proliferation compared with WT counter-
parts (Fig. 3 A). Upon activation, purified naive CD4+ 
T cells from IL-31Rα−/− mice also expressed signifi  cantly 
higher levels of IL-4 messenger RNA (mRNA; P < 0.05) 
and consistently elevated levels of IL-13 mRNA (Fig. 3 B). 
However, under Th2-polarizing conditions, similar prolifer-
ation and expression of IL-4 and IL-13 was observed be-
tween WT and IL-31Rα−/− CD4+ T cells, suggesting that 
IL-31–IL-31R interactions do not regulate diff  erentiated 
Th2 cells (Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20061791/DC1). Rather, these data dem-
onstrate that IL-31R signaling can directly infl  uence the pro-
liferation and expression of Th2 eff  ector cytokines by naive 
CD4+ T cells.
Figure 2.  Enhanced S. mansoni egg–induced type 2 infl  ammation 
in the lungs of IL-31R𝗂−/− mice. (A and B) Paraffi  n sections of lungs 
from egg-injected mice at day 14 after injection were H&E stained and 
the area of infl  ammation surrounding WT (open bar) and IL-31Rα−/− 
(closed bar) S. mansoni egg-induced granulomas was measured using 
OpenLab software. Mean ± SEM; n = 40 granulomas per group. 
(C) Draining mediastinal lymph node cells from egg-injected WT and 
IL-31Rα−/− mice were stimulated with either media or 20 μg/ml S. mansoni 
egg antigen (SEA) for 48 h. Supernatants were analyzed by ELISA for IL-4, 
-5, and -13. Mean ± SEM of replicate cultures. (D) Serum levels of IgE 
from WT and IL-31Rα−/− mice were measured by ELISA. Mean ± SEM; 
n = 3 mice per group. (E) Immunofl  uorescence staining for RELM-α (red) 
and counterstain for DAPI (blue). (F) Collagen deposition in the lungs of 
WT and IL-31Rα−/− mice was detected by Masson’s trichrome staining; 
blue staining demarks collagen. Results are representative of three inde-
pendent experiments of three mice per group. Asterisk indicates statisti-
cally signifi  cant as determined by two-tailed Student’s t test (P < 0.05). 
Bars, 60 μm.
Figure 3.  Naive IL-31R𝗂−/− CD4+ T cells exhibit enhanced prolif-
eration and expression of Th2 effector cytokines. (A) Purifi  ed naive 
CD4+ T cells from WT or IL-31Rα−/− mice were CFSE labeled and stimu-
lated with plate-bound anti-CD3/anti-CD28 for 4 d under neutral condi-
tions. Boxes to the right indicate the percentage of events in each 
proliferating generation (Gen). Numbers in italics in upper left indicate 
percentage of CFSE-dim cells. (B) cDNA derived from stimulated cells was 
assayed by real-time PCR for IL-4 or IL-13 mRNA levels relative to actin. 
Results expressed as the mean ± SEM for three independent experiments. 
*, P < 0.05; **, P < 0.1.484  IL-31 LIMITS TYPE 2 INFLAMMATION | Perrigoue et al. 
IL-31R𝗂−/− macrophages exhibit enhanced accessory 
cell function
Macrophage infi  ltration is a characteristic of S. mansoni 
egg-induced granulomas and the alternative activation of 
macrophages is necessary for survival of mouse hosts during 
S. mansoni infection (15). It has been previously reported 
that resting and activated human monocytes express IL-31Rα 
(5–7) and we have observed the induction of IL-31Rα ex-
pression on stimulated mouse macrophages (unpublished 
data). To address a role for IL-31R signaling in the regulation 
of macrophage function, WT and IL-31Rα−/− macrophages 
were pulsed overnight with OVA protein in the presence or 
absence of recombinant IL-4 and co-cultured with CFSE-
  labeled OTII transgenic OVA-specifi  c T cells. Flow cyto-
metric analysis of WT and IL-31Rα−/− bone marrow–derived 
macrophages revealed no considerable diff  erences in surface 
expression of MHC class II, CD80, or CD40 (Fig. 4 A). 
However, under both neutral and Th2-polarizing conditions, 
T cells co-cultured with IL-31Rα−/− macrophages prolifer-
ated to a greater extent than those cultured with WT macro-
phages (Fig. 4 B). When macrophages were stimulated 
with LPS and co-cultured with OVA-specifi  c CD4+ T cells 
under Th1-polarizing conditions there were no diff  erences in 
CD4+ T cell proliferation (Fig. S2, available at http://www
.jem.org/cgi/content/full/jem.20061791/DC1). These data 
support a role for IL-31R signaling in limiting innate re-
sponses by negatively regulating the T cell stimulatory func-
tion of macrophages.
IL-31R signaling specifi  cally limits type 2 immune responses
Whereas IL-31 is made predominantly by CD4+ Th2 cells, 
IL-31 mRNA expression is modestly induced by CD4+ 
T cells stimulated under both neutral and Th1 conditions (7). 
We therefore investigated whether IL-31–IL-31R signaling 
could negatively regulate type 1 immune responses in vitro 
or in vivo. Purifi  ed CD4+ T cells from naive WT and IL-
31Rα−/− mice stimulated polyclonally under Th1 polarizing 
conditions exhibited no diff  erences in their ability to prolif-
erate or acquire expression of IFN-γ as measured by intracel-
lular cytokine staining, real-time PCR, or ELISA (Fig. 5, 
A–C), indicating that IL-31R signaling does not infl  uence 
Th1 cell diff  erentiation in vitro. Furthermore, after infection 
with the intracellular parasite Leishmania major, immunity to 
which is critically dependent on IFN-γ production by CD4+ 
T cells (22), WT and IL-31Rα−/− mice exhibited equivalent 
footpad swelling, with peak lesions observed at 4 wk after 
i  nfection and control of parasite replication and resolution of 
cutaneous infl  ammation occurring by week 12 (Fig. 5, D and 
E). Consistent with the in vitro T cell diff  erentiation data 
(Fig. 5 A), the frequency of L. major–specifi  c IFN-γ–producing 
CD4+ T cells in the draining popliteal lymph node was 
  similar in infected WT and IL-31Rα−/− mice, indicating 
normal Th1 cell polarization in IL-31Rα−/− mice (Fig. 5 F). 
IL-31Rα−/− mice also displayed equivalent type 1 cytokine-
dependent resistance after infection with Listeria monocytogenes 
(unpublished data). These results suggest that IFN-γ re-
sponses are not infl  uenced by IL-31R signaling and support 
a role for IL-31–IL-31R interactions as a distinct negative 
feedback pathway operating during type 2 infl  ammation.
We have identifi  ed IL-31–IL-31R signaling as a novel 
negative regulator of type 2 infl  ammation in the lung that 
can directly infl  uence the function of antigen-presenting 
cells and CD4+ T cells. A recent study demonstrated IL-31 
transgenic mice develop spontaneous dermatitis character-
ized by alopecia and cutaneous infl  ammation, suggesting IL-31 
may have a role in promoting infl  ammation (7). The demon-
stration of a negative regulatory role for IL-31–IL-31R 
signal  ing in type 2 infl  ammation presented in this paper pro-
vides a mechanistic explanation for the observations made in 
the IL-31 transgenic mouse model. Rather than promot-
ing Th2 cytokine-mediated disease, the overexpression of 
IL-31 in transgenic mice may actively suppress Th2 responses 
with consequential augmentation of Th1 cytokine-mediated 
Figure 4.  IL-31R𝗂−/− macrophages exhibit enhanced accessory 
cell function. (A) Bone marrow–derived macrophages from either WT 
(fi  lled black) or IL-31Rα−/− (gray line) mice were characterized for surface 
molecule expression of MHC II, CD80, or CD40. Numbers refer to mean 
fl  uorescence intensity (black, WT; gray, IL-31Rα−/−). Black line is isotype 
control. (B) WT or IL-31Rα−/− macrophages were pulsed overnight with 
OVA protein in the presence or absence of IL-4 when indicated. CFSE-
labeled OTII T cells were added 24 h after OVA pulse and co-cultured with 
macrophages for 4 d under neutral or Th2-polarizing conditions. Histo-
grams are gated on the live CD4+ population; boxes to the right indicate 
the percentage of events in each proliferating generation (Gen). Numbers 
in italics in top left indicate percentage of CFSE-dim cells. Data are repre-
sentative of six independent experiments.JEM VOL. 204, March 19, 2007  485
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  infl  ammation in the skin. Although no analysis of cytokine 
expression in the skin of IL-31 transgenic mice was per-
formed in that study (7), the elevated type 2 infl  ammation 
observed in the lungs of IL-31Rα−/− mice is consistent with 
this interpretation of the results.
In the present study, we identify a regulatory function for 
IL-31–IL-31R interactions in an acute model of type 2 in-
fl  ammation in the lung; although whether this pathway infl  u-
ences pathologic consequences of chronic type 2 infl  ammation 
such as fi  brosis and tissue remodeling will require further 
  investigation. Notwithstanding this, a negative regulatory 
function for IL-31R is supported by in vitro studies that 
identifi  ed STAT3, a transcription factor associated with sup-
pression of DC, T cell, NK, and neutrophil functions (23), as 
the dominant STAT pathway activated after IL-31R ligation 
(4–7). The IL-27–IL-27R pathway is another gp130 family 
member that can negatively regulate infl  ammatory responses 
in multiple disease settings (24–27). However, the IL-31–IL-
31R pathway is unique in at least two aspects. First, IL-31 is 
expressed by diff  erentiated CD4+ Th2 cells, whereas IL-27 is 
expressed by antigen-presenting cells. Second, unlike IL-27–
IL-27R interactions, IL-31R–mediated suppression appears 
to be specifi  c for Th2 cytokine responses as defi  ciency in IL-
31Rα does not infl  uence Th1 cell diff  erentiation in vitro or 
the magnitude of the Th1 cytokine response to intracellular 
pathogens. This specifi  city in function highlights the poten-
tial of manipulating the IL-31–IL-31R signaling pathway in 
the treatment of infl  ammatory diseases characterized by over-
expression of Th2 cytokines at mucosal sites.
MATERIALS AND METHODS
Mice. WT C57BL/6 mice and OTII transgenic mice were ordered from 
the Jackson Laboratory. Mice were bred in a specifi  c pathogen–free envi-
ronment at the University of Pennsylvania. All experiments were performed 
following the guidelines of the University of Pennsylvania Institutional 
Animal Care and Use Committee. IL-31Rα−/− mice were generated by 
constructing a targeting vector that deleted the cytokine receptor homol-
ogy domain of IL-31Rα (encoded by exons 5–8 of the mouse transcript) 
from the following DNA fragments: a 5′ homology arm of 5,289 bp was 
a PCR-amplifi  ed fragment from C57/BL6 genomic DNA using primers 
5′-T  T  A  A  T  T  A  A  A  T  C  T  A  C  A  T  G  T  G  T  G  C  G  G  A  G  G  C  -3′ and 5′-G  C  G  G  C-
C  G  C  A  T  G  T  T  C  T  C  T  G  G  C  T  T  A  G  T  C  G  G  C  A  G  G  -3′; a PGK-neo resistance 
cassette; a 3′ homology arm of 1,108 bp short arm defi  ned by primers 
5′-G  G  C  G  C  G  C  C  A  G  G  G  G  T  G  G  T  G  G  T  G  G  A  T  G  G  A  T  -3′ and 5′-G  G  C  G-
C  G  C  C  G  T  C  T  A  C  A  G  G  G  T  T  A  A  C  C  T  A  -3′ (Fig. 1 A); and an HSV-driven 
thymidine kinase selection cassette for negative selection. This construct was 
electroporated into C57BL/6 embryonic stem (ES) cells, and homologous 
recombination occurred in 4 out of 200 clones after selection with G418 
and ganciclovir. To verify correct targeting of the locus, genomic DNA 
from ES cells and animals was analyzed by Southern blot. Digestion with 
SacI followed by hybridization of membranes with probe 1 (a 2,400-bp ge-
nomic DNA fragment obtained by PCR with oligos 5′-G  A  G  C  T  C  C  C  G  G-
G  A  T  C  A  C  G  T  C  C  -3′ [sense] and 5′-A  G  G  C  C  T  C  C  T  C  T  G  G  A  G  C  T  G  G  G  -3′ 
[antisense]) yielded an 11,904-bp fragment for the WT allele and an 8,877-bp 
fragment for the correctly targeted mutant allele. Similarly, digestion of 
  genomic DNA with BamHI followed by hybridization of membranes with 
probe 2 (a 1,028-bp genomic DNA fragment obtained by PCR with oligos 
5′-A  T  C  G  A  T  A  G  G  T  T  C  A  G  T  G  G  T  A  -3′ [sense] and 5′-A  A  G  T  A  C  T  G  T  A  T-
G  T  G  G  T  A  G  C  C  -3′ [antisense]) yielded a 6,990-bp fragment for the WT allele 
and a 9,401-bp fragment for the correctly targeted mutant allele. Two ES cell 
clones were injected into blastocysts, and animals that transmitted the mutant 
allele in their germline were obtained. For genotyping, a PCR-based method 
with a common antisense primer (5′-G  G  C  A  G  T  A  A  C  T  G  A  A  G  T  A  A  C  A  G  -3′) 
in combination with WT- (5′-C  A  A  A  G  T  C  A  C  A  A  T  G  T  A  G  C  T  G  G  -3′) and 
Figure 5.  Normal Th1 cell differentiation in IL-31R𝗂−/− mice. 
(A) Purifi  ed CD4+ T cells from WT and IL-31Rα−/− mice were CFSE 
labeled and stimulated with plate-bound anti-CD3/anti-CD28 under Th1-
polarizing conditions. Cells were assayed for proliferation and cytokine 
production by fl  ow cytometry. The top number indicates the percentage 
of proliferating CD4+ T cells producing IFN-γ and the bottom number in 
italics is the percentage of CFSE-dim cells. (B) cDNA from purifi  ed naive 
CD4+ T cells cultured under Th1-polarizing conditions was subjected to 
real-time PCR analysis for IFN-γ expression relative to actin. (C) Superna-
tants from the cultures in A were assayed by ELISA for IFN-γ levels. 
(D) WT and IL-31Rα−/− mice were infected with L. major promastigotes in 
the hind footpad. Lesion size was determined by measuring swelling of 
the infected footpad and subtracting that of the uninfected contralateral 
footpad. (E) Parasite load in the footpad was quantifi  ed by limiting dilu-
tion analysis at 12 wk after infection. Values represent the mean ± SEM 
for three mice per group. (F) Cells from the draining lymph nodes of 
L. major– infected WT or IL-31Rα−/− mice were restimulated with soluble 
L. major antigen and analyzed by fl  ow cytometry. Plots are gated on CD4+ 
cells and the number in the box indicates the percentage of CD4+ T cells 
producing IFN-γ.486  IL-31 LIMITS TYPE 2 INFLAMMATION | Perrigoue et al. 
knockout-specifi  c (5′-C  G  C  C  T  T  C  T  T  G  A  C  G  A  G  T  T  C  T  T  -3′) sense prim-
ers was used. This primer-triplet amplifi  es a 492-bp fragment for the 
WT allele and an 808-bp fragment for the mutant allele. PCR was per-
formed in a thermocycler (model PE9700; PerkinElmer) using the following 
conditions: 1 cycle of 94°C, 4’; 35 cycles of 94°C, 30”, 60°C, 30”, and 72°C, 
60”; and 1 cycle of 72°C, 7’. IL-31Rα−/− mice were born at Mendelian 
frequencies and were equivalent in size, weight, and fertility to littermate 
controls. No abnormalities in organ development or infl  ammation were 
found upon histopathological examination, and analysis of clinical chemistry 
and hematology parameters did not reveal differences between WT and 
IL-31Rα−/− mice.
FACS analysis of blood cell subsets. Spleens, thymi, and lymph nodes 
were isolated from 6–8-wk-old mice and single cell suspensions were prepared. 
Peripheral blood was obtained by cardiac puncture and treated with EDTA to 
prevent coagulation, and erythrocytes were lysed using ACK lysing buff  er 
(Biosource International). All cells were incubated for 30 min on ice in Hanks’ 
balanced salt solution supplemented with 2% heat-inactivated bovine calf 
s  erum. Cells were stained with fl  uorochrome-conjugated antibodies against 
CD4, CD8, CD11b, CD11c, CD25, CD62L, B220, F4/80, and NK1.1 and 
analyzed using a FACSCalibur fl  ow cytometry system (BD Biosciences).
S. mansoni granuloma model. WT C57BL/6 or IL-31Rα−/− mice were 
injected i.v. with 5,000 S. mansoni eggs. At day 14 after primary injection, ani-
mals were killed. Lungs were infl  ated with 4% paraformaldehyde, embedded 
in paraffi   n, cut in 5-μm sections, and stained with hematoxylin and eosin 
(H&E) or Masson’s trichrome. H&E sections were analyzed using Openlab 
software (Improvision) to assess the area of egg-induced infl  ammation by sub-
tracting the area of the egg from the total area of the granuloma for each gran-
uloma in a section. Paraffi   n sections were analyzed for expression of RELM-α 
by immunofl   uorescence via incubation with an anti–RELM-α antibody 
(1:1,000; PeproTech) followed by addition of a Cy3-conjugated anti-rat 
  secondary antibody (1:600; The Jackson Laboratory). Serum was assayed by 
ELISA for IgE using OptIEA IgE kit (BD Biosciences). Single cell suspensions 
of draining cranial mediastinal lymph nodes from egg-injected mice or periph-
eral lymph nodes from naive mice were plated at 1.5 million/ml in complete 
media (DMEM [Life Technologies] supplemented with 10% heat-inactivated 
FBS, 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM l-glutamine, and 
50 μM 2-mercaptoethanol) and stimulated for 48 h with either media alone 
or 20 μg/ml of soluble S. mansoni egg antigen (SEA). Supernatants were 
  assayed for IL-4, -5, and -13 using standard sandwich ELISA protocols.
T cell proliferation assays. Naive CD4+ T cells were isolated via negative 
depletion with a naive CD4+ T cell column from R&D Systems (purity 
>90% CD4+, CD44low, and CD62Lhigh), labeled with 5 μg/ml CFSE 
(Invitrogen), and stimulated with 1 μg/ml of plate-bound anti-CD3/anti-
CD28 (eBioscience) under neutral or Th2- (40 ng/ml IL-4 [R&D Systems], 
10 μg/ml anti–IL-12 [C17.8], and 50 μg/ml anti–IFN-γ [XMG-6]) polar-
izing conditions. At day 4 cells were stimulated with 50 ng/ml PMA (Sigma-
  Aldrich), 500 ng/ml ionomycin (Sigma-Aldrich), and 10 μg/ml brefeldin A 
(Sigma-Aldrich) for 4 h. After stimulation, cells were surface stained for 
CD4, fi  xed, acquired on a FACSCalibur cytometer, and analyzed using 
FloJo software (Tree Star) for proliferation. Purifi  ed CD4+ T cells for in vitro 
Th1 cell diff  erentiation assays were obtained by subjecting whole spleen and 
lymph node suspensions to negative selection via incubation with hybridoma 
supernatants (αB220, αFCR, αCD8, and αMHCII) followed by magnetic 
bead purifi  cation (QIAGEN), CFSE labeled, and stimulated with 1 μg/ml 
anti-CD3/anti-CD28 in the presence of 1 ng/ml rIL-12 and 10 μg/ml 
anti–IL-4 (11B11). On day 4, cells were harvested and subjected to fl  ow 
  cytometric analysis.
Real-time PCR. RNA was purifi  ed from cells in culture per instructions 
using an RNeasy kit (QIAGEN). cDNA was generated per standard proto-
col with Superscript reverse transcriptase (Invitrogen) and used as input for 
real-time PCR. Taqman PCR reactions were run at standard conditions 
  using a sequence detector (ABI 7500; Applied Biosystems). Taqman Assays 
on Demand (Applied Biosystems) were used to measure β-actin, IL-4, IL-13, 
and IFN-γ message levels.
Macrophage: T cell co-culture. Macrophages were derived in vitro as 
follows. Bone marrow from C57BL/6 or IL-31Rα−/− mice was plated on 
10-cm petri dishes in DMEM supplemented with 100 μg/ml penicillin/
streptomycin, 10% FCS, 1% sodium pyruvate, 25 mM Hepes, and 30% 
l-cell–conditioned media. Media was changed at 3 d and cells were harvested 
at day 7. Bone marrow–derived macrophages from WT or IL-31Rα−/− mice 
were plated at 5 × 105 cells/well and pulsed overnight with 500μg/ml OVA 
protein (Worthington) in the presence or absence of 40 ng/ml IL-4 (R&D 
Systems). Purifi  ed OTII T cells were obtained by passing whole spleen and 
lymph node suspensions over T cell enrichment columns (R&D Systems). 
OTII T cells were CFSE labeled and co-cultured with macrophages at a 4:1 
ratio at which time anti–IFN-γ and IL-4 were added for Th2-polarizing 
conditions in the IL-4–primed macrophage cultures. At day 4, cells were 
stimulated with PMA, ionomycin, and brefeldin A for 4 h and analyzed by 
fl  ow cytometry. For Th1-polarizing conditions, macrophages were primed 
with 10 ng/ml LPS and OVA. OT II T cells were CFSE-labeled and added 
at a 4:1 ratio with 1 ng/ml IL-12 and 10 μg/ml anti–IL-4 (11B11).
L. major infection and parasite titers. L. major parasites (MHOM/IL/80/
Friedlin) were grown in Grace’s insect culture medium (Life Technologies) 
supplemented with 20% heat-inactivated FBS (HyClone Laboratories), 2 mM 
l-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin (Sigma-
  Aldrich). Soluble Leishmanial antigen was prepared as previously described 
(28). Mice were injected in the hind left footpad with 5 × 106 parasites. 
Footpad swelling was measured weekly using digital calipers (Mitutoyo), and 
lesion size was determined by subtracting the size of the uninfected contra-
lateral footpad from the size of the infected footpad. To quantify parasites in 
the footpad, single-cell suspensions of lesions were prepared and plated in 
twofold serial dilutions (initial dilution of 1:100) in Grace’s insect culture 
medium. Each sample was plated in quadruplicate, and the mean of the neg-
ative log parasite titer was determined after 7 d of culture at 26°C.
Statistics. Statistical analysis was performed using a two-tailed Student’s 
t test (*, P < 0.05).
Online supplemental material. The immune cell composition of the thy-
mus, spleen, lymph nodes, and peripheral blood of WT or IL-31Rα−/− 
mice is shown in Table S1. Naive WT and IL-31Rα−/− T cell proliferation 
and cytokine production under Th2-polarizing conditions is shown in Fig. S1. 
Fig. S2 shows the proliferation of OVA-specifi  c TCR transgenic T cells iso-
lated from OTII mice co-cultured with LPS-primed, OVA-pulsed WT 
or IL-31Rα−/− macrophages. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20061791/DC1.
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